Bromodeoxyuridine Labeling Index as an Indicator of Early Tumor Response to Preoperative Radiotherapy in Patients with Rectal Cancer

PURPOSE: Assessment of tumor proliferation rate using Bromodeoxyuridine labeling index (BrdUrdLI) as a possible predictor of rectal cancer response to preoperative radiotherapy (RT). METHODS AND MATERIAL: Ninety-two patients were qualified either to short RT (5 Gy/fraction/5 days) and surgery about...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasinska, Anna, Skolyszewski, Jan, Popiela, Tadeusz, Richter, Piotr, Darasz, Zbigniew, Nowak, Krystyna, Niemiec, Joanna, Biesaga, Beata, Adamczyk, Agnieszka, Bucki, Krzysztof, Malecki, Krzysztof, Reinfuss, Marian, Kowalska, Teresa
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852386/
https://www.ncbi.nlm.nih.gov/pubmed/17436139
http://dx.doi.org/10.1007/s11605-007-0127-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1852386/
https://www.ncbi.nlm.nih.gov/pubmed/17436139
http://dx.doi.org/10.1007/s11605-007-0127-x

Ejemplares similares